» Articles » PMID: 20840332

The Effect of Changes in Thyroxine and Thyroid-stimulating Hormone Levels on the Coagulation System

Overview
Publisher Elsevier
Specialty Hematology
Date 2010 Sep 16
PMID 20840332
Citations 6
Authors
Affiliations
Soon will be listed here.
Citing Articles

Association between hyperthyroidism and thromboembolism: A retrospective observational study.

Alsaidan A, Alruwiali F Ann Afr Med. 2023; 22(2):183-188.

PMID: 37026199 PMC: 10262864. DOI: 10.4103/aam.aam_105_22.


Evaluation of hemostasis in hyperthyroid cats.

Keebaugh A, DeMonaco S, Panciera D, Abbott J, Boes K, Menciotti G J Vet Intern Med. 2021; 35(6):2636-2645.

PMID: 34590754 PMC: 8692217. DOI: 10.1111/jvim.16274.


Free Triiodothyronine Connected With Metabolic Changes in Patients With Coronary Artery Disease by Interacting With Other Functional Indicators.

Tian X, Zheng S, Liu J, Wu Y, Lin L, Chen H Front Mol Biosci. 2021; 8:681955.

PMID: 34395522 PMC: 8362995. DOI: 10.3389/fmolb.2021.681955.


Assessment of the Impact of L-Thyroxine Therapy on Bleeding Risk in Patients Receiving Vitamin K Antagonists.

Moustafa F, Malhomme R, Pereira B, Barres A, Saint-Denis J, Dutheil F Clin Drug Investig. 2017; 37(10):929-936.

PMID: 28612237 DOI: 10.1007/s40261-017-0545-9.


Major Haemorrhage during Vitamin K Antagonist Treatment: The Influence of Thyroid Hormone Levels.

Debeij J, Cannegieter S, van Zaane B, van Zanten A, Rosendaal F, Gerdes V Eur Thyroid J. 2014; 3(1):32-7.

PMID: 24847463 PMC: 4005261. DOI: 10.1159/000357578.